35 related articles for article (PubMed ID: 15828169)
1. Interaction of Chloramphenicol Tripeptide Analogs with Ribosomes.
Tereshchenkov AG; Shishkina AV; Tashlitsky VN; Korshunova GA; Bogdanov AA; Sumbatyan NV
Biochemistry (Mosc); 2016 Apr; 81(4):392-400. PubMed ID: 27293096
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Chloramphenicol Cationic Peptide Analogues with the Ribosome.
Khairullina ZZ; Tereshchenkov AG; Zavyalova SA; Komarova ES; Lukianov DA; Tashlitsky VN; Osterman IA; Sumbatyan NV
Biochemistry (Mosc); 2020 Nov; 85(11):1443-1457. PubMed ID: 33280584
[TBL] [Abstract][Full Text] [Related]
3. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition.
Svetlov MS; Plessa E; Chen CW; Bougas A; Krokidis MG; Dinos GP; Polikanov YS
RNA; 2019 May; 25(5):600-606. PubMed ID: 30733327
[TBL] [Abstract][Full Text] [Related]
4. Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.
Brakel A; Krizsan A; Itzenga R; Kraus CN; Otvos L; Hoffmann R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328571
[TBL] [Abstract][Full Text] [Related]
5. Modeling Interactions of Erythromycin Derivatives with Ribosomes.
Shishkina AV; Makarova TM; Tereshchenkov AG; Makarov GI; Korshunova GA; Bogdanov AA
Biochemistry (Mosc); 2015 Nov; 80(11):1500-7. PubMed ID: 26615442
[TBL] [Abstract][Full Text] [Related]
6. Investigation of radezolid interaction with non-canonical chloramphenicol binding site by molecular dynamics simulations.
Makarov GI; Reshetnikova RV
J Mol Graph Model; 2021 Jun; 105():107902. PubMed ID: 33798835
[TBL] [Abstract][Full Text] [Related]
7. Chloramphenicol Derivatization in Its Primary Hydroxyl Group with Basic Amino Acids Leads to New Pharmacophores with High Antimicrobial Activity.
Tsirogianni A; Kournoutou GG; Mpogiatzoglou M; Dinos G; Athanassopoulos CM
Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237735
[TBL] [Abstract][Full Text] [Related]
8. The macrolide antibiotic renaissance.
Dinos GP
Br J Pharmacol; 2017 Sep; 174(18):2967-2983. PubMed ID: 28664582
[TBL] [Abstract][Full Text] [Related]
9. Chloramphenicol Derivatives as Antibacterial and Anticancer Agents: Historic Problems and Current Solutions.
Dinos GP; Athanassopoulos CM; Missiri DA; Giannopoulou PC; Vlachogiannis IA; Papadopoulos GE; Papaioannou D; Kalpaxis DL
Antibiotics (Basel); 2016 Jun; 5(2):. PubMed ID: 27271676
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes.
Brandt-Rauf P; Vince R; LeMahieu R; Pestka S
Antimicrob Agents Chemother; 1978 Jul; 14(1):88-94. PubMed ID: 356727
[TBL] [Abstract][Full Text] [Related]
11. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
Pestka S; Nakagawa A; Omura S
Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
[TBL] [Abstract][Full Text] [Related]
12. Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes.
Pestka S; Lemahieu R; Miller P
Antimicrob Agents Chemother; 1974 Oct; 6(4):489-91. PubMed ID: 4157350
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics.
Pestka S
Antimicrob Agents Chemother; 1974 Mar; 5(3):255-67. PubMed ID: 4599122
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of ribosome functions.
Pestka S
Annu Rev Microbiol; 1971; 25():487-562. PubMed ID: 4949424
[No Abstract] [Full Text] [Related]
15. Inhibition of [14C]chloramphenicol binding to Escherichia coli ribosomes by erythromycin derivatives.
Pestka S; LeMahieu RA
Antimicrob Agents Chemother; 1974 Jul; 6(1):39-45. PubMed ID: 15828169
[TBL] [Abstract][Full Text] [Related]
16. Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.
Pestka S; Lemahieu RA
Antimicrob Agents Chemother; 1974 Oct; 6(4):479-88. PubMed ID: 4157349
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
